Ritholtz Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
128,403
+43,745
+52% +$982K 0.04% 317
2026
Q1
$1.91M Buy
84,658
+60,652
+253% +$1.39M 0.03% 383
2025
Q4
$572K Buy
24,006
+5,595
+30% +$139K 0.01% 674
2025
Q3
$485K Sell
18,411
-530
-3% -$13.6K 0.01% 690
2025
Q2
$541K Buy
18,941
+237
+1% +$6.36K 0.01% 617
2025
Q1
$466K Sell
18,704
-826
-4% -$19.7K 0.01% 613
2024
Q4
$442K Sell
19,530
-844
-4% -$18.3K 0.01% 600
2024
Q3
$434K Sell
20,374
-16,527
-45% -$325K 0.01% 597
2024
Q2
$704K Buy
36,901
+895
+2% +$18.2K 0.02% 434
2024
Q1
$694K Buy
36,006
+5,769
+19% +$114K 0.02% 455
2023
Q4
$630K Buy
30,237
+5,059
+20% +$97.2K 0.02% 437
2023
Q3
$542K Buy
+25,178
New +$611K 0.02% 437

Other funds holding FMS

Ritholtz Wealth Management's FMS Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Fresenius Medical Care (FMS) stake by 52% in Q2 2026, buying an estimated $982K and bringing the position to 128,403 shares worth $2.9M. The position accounts for 0.04% of the portfolio, ranked #317.

Ritholtz Wealth Management first reported a position in FMS in Q3 2023 and has held it in 12 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Ritholtz Wealth Management held 128,403 shares of Fresenius Medical Care worth $2.9M as of Q2 2026.
  • Ritholtz Wealth Management bought 43,745 Fresenius Medical Care shares in Q2 2026, an estimated $982K.
  • Fresenius Medical Care made up 0.04% of Ritholtz Wealth Management's portfolio in Q2 2026, its #317 holding.
  • Ritholtz Wealth Management first reported a position in Fresenius Medical Care in Q3 2023 and has held it in 12 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.